Development of High Boron Content Liposomes and Their Promising Antitumor Effect for Neutron Capture Therapy
- 1 December 2013
- journal article
- abstracts
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 133 (12) , 1297-1306
Abstract
High accumulation and selective delivery of boron into tumor tissue are the most important requirements to achieve the efficient cell-killing effect of boron neutron capture therapy (BNCT) that relies on the nuclear reaction of two essentially nontoxic species, boron-10 (10B) and thermal neutrons in boron-loaded tissues. Recent development of boron cluster lipids and their liposomal boron delivery system (BDS) are summarized in this article. Boron compounds that have no affinity to tumor can potentially be delivered to tumor tissues by liposomes, therefore, liposomal BDS would be one of the most attractive approaches for efficient BNCT of various cancers. There are two approaches for BDS: encapsulation of boron compounds into liposomes and incorporation of boron-conjugated lipids into the liposomal bilayer. The combination of both approaches has a potential for reduction of the total dose of liposomes without reducing the efficacy of BNCT.Keywords
This publication has 22 references indexed in Scilit:
- Boron neutron capture therapy for glioblastomaCancer Letters, 2008
- First Attempt of Boron Neutron Capture Therapy (BNCT) for Hepatocellular CarcinomaJapanese Journal of Clinical Oncology, 2007
- First clinical case of boron neutron capture therapy for head and neck malignancies using 18F‐BPA PETHead & Neck, 2006
- Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimagesJournal of Neurosurgery, 2005
- Boron Neutron Capture Therapy of Cancer: Current Status and Future ProspectsClinical Cancer Research, 2005
- Effectiveness of BNCT for recurrent head and neck malignanciesApplied Radiation and Isotopes, 2004
- New Thermal Neutron Capture Therapy for Malignant Melanoma: Melanogenesis‐Seeking 10B Molecule‐Melanoma Cell Interaction From In Vitro to First Clinical TrialPigment Cell Research, 1989
- A revised boron-neutron capture therapy for malignant brain tumorsJournal of Neurology, 1975
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967
- Synthesis of Aromatic Boronic Acids. Aldehydo Boronic Acids and a Boronic Acid Analog of Tyrosine1Journal of the American Chemical Society, 1958